曾德平's scrapbook. (Photo: ©joschmaltz on Flickr.) CC License CC-BY-NC-SA 2.0.
 

Podcast: Stopping The Next Outbreak – Health Threats Inevitable, But Catastrophes Preventable: An insider's perspective on global health crises and the challenging work of CDC

Podcast: Stopping The Next Outbreak – Health Threats Inevitable, But Catastrophes Preventable: An insider

Please upgrade to a browser that supports HTML5 audio or install Flash.

Audio MP3 Download Podcast

Duration: 1:14:16

Dr. Anne Schuchat, Acting Director, Centers for Disease Control on "Stopping the next outbreak – Health threats inevitable, but catastrophes preventable: An insider’s perspective on global health crises and the challenging work of CDC"

ABOUT THE SPEAKER

ANNE SCHUCHAT, M.D.
Acting Director
Centers for Disease Control and Prevention
Acting Administrator
Agency for Toxic Substances and Disease Registry
Rear Admiral
U.S. Public Health Service


Anne Schuchat, M.D. became Acting Director for CDC in January 2017.

Dr. Schuchat began her public health career in 1988 when she came to CDC as an Epidemic Intelligence Service officer. She was principal deputy director of CDC during 2015-2017 and director of CDC's National Center for Immunization and Respiratory Diseases from 2006-2015. Other CDC leadership posts include: acting director of the Center for Global Health (2012-13) and the National Center for Infectious Diseases (2005) as well as Chief of the Respiratory Diseases Branch (1998-2005). Dr. Schuchat was the initial medical director of ABCs – the Active Bacterial Core surveillance of the Emerging Infections Program Network and spearheaded prevention of newborn infection from group B streptococcal disease in the 1990s. She was promoted to Rear Admiral in the Commissioned Corps of the United States Public Health Service in 2006 and earned a second star in 2010. Dr. Schuchat was elected to the National Academy of Medicine (formerly the Institute of Medicine) in 2008.

Dr. Schuchat has played key roles in a number of CDC emergency responses. Most notably, she served as Chief Health Officer for CDC’s 2009 H1N1 pandemic influenza response; led the CDC team responding to the SARS outbreak in Beijing in 2003; and supported the Washington D.C. field team during the 2001 bioterrorist anthrax response.

Globally, Dr. Schuchat has worked in West Africa on meningitis, pneumonia, and Ebola vaccine trials; in South Africa on surveillance and prevention projects, and represented technical and health research institutes on the GAVI Alliance board. She has authored or co-authored more than 230 scientific articles, book chapters, and reviews. Her contributions have been recognized by receipt of USPHS Meritorious Service Medals, the American Public Health Association's Maternal and Child Health Young Investigator Award, the USPHS Physician Research Officer of the Year, and an Honorary Doctorate in Science from Swarthmore College. Dr. Schuchat graduated with highest honors from Swarthmore College and with honors from the Geisel School of Medicine at Dartmouth and completed her residency and chief residency in internal medicine at NYU’s Manhattan VA Hospital.



IN CONVERSATION WITH

THOMAS J. COATES, PhD, is Director of the UCLA Center for World Health, which advances the international and global health mission of the David Geffen School of Medicine and UCLA Health. He is Director of the University of California Global Health Institute, which advances the mission of the 10-campus UC system to improve the lives of people in California and around the world. He is the Michael and Sue Steinberg Endowed Professor of Global AIDS Research within the Division of Infectious Diseases at UCLA. He co-founded the Center for AIDS Prevention Studies at UCSF in 1986 and directed it from 1991 to 2003, and was the founding Executive Director of the UCSF AIDS Research Institute, leading it from 1996 to 2003. His areas of emphasis and expertise are global health, HIV prevention and its relationship to treatment, and international health policy. With funding from USAID and WHO, he led a randomized controlled trial to determine the efficacy and cost-effectiveness of HIV voluntary counseling and testing for individuals and couples in Kenya, Tanzania, and Trinidad. He has just completed directing a 48-community randomized clinical trial (NIMH Project Accept/HPTN 043) in South Africa, Zimbabwe, Tanzania, and Thailand to determine the impact of strategies for mobile HIV voluntary counseling and testing and for changing community norms on HIV incidence at the community level.
Dr. Coates was cited in Science in 2002 as the 4th-highest-funded scientist in the clinical, social, and behavioral sciences. He was elected to the Institute of Medicine (IOM) in 2000, and has served on the IOM’s Board on Global Health.



This event is co-sponsored by the UCLA Center for World Health and the Health and Human Rights Law Project at the UCLA School of Law.